Measurement of prebeta-1 HDL in human plasma by an ultrafiltration- isotope dilution technique

Analytical Biochemistry

Volumn 251, Issue 2, 1997, Pages 234-240

  O'Connor, P M ^a   Naya Vigne, J M ^a   Duchateau, P N ^a   Ishida, B Y ^a   Mazur, M ^a   Schoenhaus, S A ^a   Zysow, B R ^b   Malloy, M J ^a   Kunitake, S T ^c   Kane, J P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GENENTECH INC   (United States)

^c Biometric Imaging   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYMES; ISOTOPES; ULTRAFILTRATION;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH-DENSITY LIPOPROTEINS; ISOTOPE DILUTION TECHNIQUE; ISOTOPE DILUTIONS; PLASMA SAMPLES; SPECIFIC ACTIVITY;

LIPOPROTEINS;

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; TRITIUM;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOTOPE DILUTION ASSAY; LIPOPROTEIN SYNTHESIS; MALE; MEMBRANE PERMEABILITY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; SPECIES DIFFERENTIATION; ULTRAFILTRATION;

TRITIUM;

EID: 0031554902     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1006/abio.1997.2258     Document Type: Article

References (29)

1. Havel R. J., Eder H. A., Bragdon J. H. J. Clin. Invest. 34:1955;1345-1353.
2. Lindgren F., Nichols A. The Plasma Lipoproteins: Biosynthesis, Metabolism, Alterations in Disease. 1960;Academic Press. p. 1-58.
3. Kunitake S. T., Kane J. P. J. Lipid Res. 23:1992;936-940.
4. McVicar J. P., Kunitake S. T., Hamilton R. L., Kane J. P. Proc. Natl. Acad. Sci. USA. 81:1984;1356-1360.
5. Kunitake S. T., La Sala K. J., Kane J. P. J. Lipid Res. 26:1985;549-553.
6. Fielding C. J., Fielding P. E. J. Lipid Res. 36:1995;211-228.
7. S. T. Kunitake, K. J. La Sala, C. M. Mendel, G. C. Chen, J. P. Kane, Sept. 1987, National Institutes of Health Workshop on Lipoprotein Heterogeneity, 419, 427.
8. Hennessy L. K., Kunitake S. T., Kane J. P. Biochemistry. 32:1993;5759-5765.
9. Kane J. P. Plasma Lipoproteins and Coronary Artery Disease. 1992;Blackwell Scientific, Boston. p. 125-150.
10. Castro G. R., Fielding C. J. Biochemistry. 27:1988;25-29.
11. von Eckardstein A., Huang Y., Assmann G. Curr. Opin. Lipidol. 5:1994;404-416.
12. von Eckardstein A., Huang Y., Wu S., Funke H., Noseda G., Assmann G. Arteriosclerosis Thromb. Vasc. Biol. 15:1995;691-703.
13. Ishida B. Y., Frohlich J., Fielding C. J. J. Lipid Res. 28:1987;778-786.
14. Neary R., Bhatnagar D., Durrington P., Ishola M., Arrol S., Mackness M. Atherosclerosis. 89:1991;35-48.
15. O'Kane M., Wisdom G., McEneny J., McFerran N., Trimble E. Clin. Chem. 38:1992;2273-2277.
16. Neary R. H., Gowland E. Clin. Chem. 33:1987;1163-1169.
17. Eisenberg S., Gavish D., Oschry Y., Fainaru M., Deckelbaum R. I. J. Clin. Invest. 74:1984;470-482.
18. Atmeh R. F., Robenek H. J. Lipid Res. 37:1996;2461-2469.
19. Schonfeld G., Bailey A., Steelman R. Lipids. 13:1978;951-959.
20. Duval F., Frommherz K., Atger V., Drueke T., Lacour B. Clin. Chem. 35:1989;963-966.
21. Barrans A., Collet X., Barbaras R. J. Biol. Chem. 269:1994;11572-11577.
22. Asztalos B. F., Sloop C. M., Wong L., Roheim P. S. Biochem. Biophys. Acta. 1169:1993;291-300.
23. Asztalos B., Sloop C., Wong L., Roheim P. Biochim. Biophys. Acta. 1169:1993;301-304.
24. Asztalos B., Roheim P. Arteriosclerosis Thromb. Vasc. Biol. 15:1995;1419-1423.
25. Francone P. L., Gurakar A., Fielding C. J. J. Biol. Chem. 264:1989;7066-7072.
26. Bachorik P., Albers J. Methods in Enzymology. 1986;Academic Press, San Diego. p. 78-100.
27. Fink D., Gainer H. Science. 208:1980;303-305.
28. Folch J., Lees M., Sloane-Stanley G. H. J. Biol. Chem. 226:1957;497-509.
29. Kunitake S. T., O'Connor P., Naya-Vigne J. Bradley G., Segrest. Methods in Enzymology. 1996;260-267 Academic Press, San Diego.